Rosa Catalán

1.2k total citations
29 papers, 866 citations indexed

About

Rosa Catalán is a scholar working on Psychiatry and Mental health, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, Rosa Catalán has authored 29 papers receiving a total of 866 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Psychiatry and Mental health, 11 papers in Cellular and Molecular Neuroscience and 10 papers in Pharmacology. Recurrent topics in Rosa Catalán's work include Bipolar Disorder and Treatment (10 papers), Neurotransmitter Receptor Influence on Behavior (10 papers) and Schizophrenia research and treatment (9 papers). Rosa Catalán is often cited by papers focused on Bipolar Disorder and Treatment (10 papers), Neurotransmitter Receptor Influence on Behavior (10 papers) and Schizophrenia research and treatment (9 papers). Rosa Catalán collaborates with scholars based in Spain, Italy and United States. Rosa Catalán's co-authors include Bárbara Arias, Cristòbal Gastó, Lourdes Fañanás, Blanca Gutiérrez, Alessandro Serretti, Sergi Papiol, Marina Mitjans, Miquel Bernardo, Cristina Lorenzi and Rafael Penadés and has published in prestigious journals such as Journal of Affective Disorders, Psychopharmacology and Frontiers in Psychology.

In The Last Decade

Rosa Catalán

26 papers receiving 846 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rosa Catalán Spain 16 283 281 258 209 182 29 866
Silvia Paddock United States 9 199 0.7× 206 0.7× 286 1.1× 181 0.9× 211 1.2× 17 826
Alexa J.M. Sorant United States 10 262 0.9× 260 0.9× 367 1.4× 242 1.2× 243 1.3× 20 1.0k
Jeffrey Kraft United States 9 247 0.9× 317 1.1× 301 1.2× 262 1.3× 250 1.4× 13 987
Johannes M. Hennings Germany 18 274 1.0× 195 0.7× 255 1.0× 178 0.9× 323 1.8× 32 1.1k
Christo Minov Germany 12 190 0.7× 302 1.1× 155 0.6× 254 1.2× 140 0.8× 19 768
Rhee-Hun Kang South Korea 13 161 0.6× 288 1.0× 178 0.7× 147 0.7× 142 0.8× 14 725
Yoshiteru Takekita Japan 16 321 1.1× 201 0.7× 239 0.9× 211 1.0× 157 0.9× 48 845
Bianca Wollenhaupt de Aguiar Brazil 19 198 0.7× 217 0.8× 107 0.4× 105 0.5× 261 1.4× 30 833
Hitoshi Maeshima Japan 20 240 0.8× 116 0.4× 119 0.5× 148 0.7× 262 1.4× 35 806
Myoung-Jin Choi South Korea 11 139 0.5× 296 1.1× 180 0.7× 152 0.7× 142 0.8× 11 603

Countries citing papers authored by Rosa Catalán

Since Specialization
Citations

This map shows the geographic impact of Rosa Catalán's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosa Catalán with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosa Catalán more than expected).

Fields of papers citing papers by Rosa Catalán

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rosa Catalán. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosa Catalán. The network helps show where Rosa Catalán may publish in the future.

Co-authorship network of co-authors of Rosa Catalán

This figure shows the co-authorship network connecting the top 25 collaborators of Rosa Catalán. A scholar is included among the top collaborators of Rosa Catalán based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rosa Catalán. Rosa Catalán is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ramis, Damià, et al.. (2025). Bicytopenia in the Context of Olanzapine Treatment. Journal of Clinical Psychopharmacology. 45(3). 296–298.
2.
Penadés, Rafael, et al.. (2024). Treating Cognition in Schizophrenia: A Whole Lifespan Perspective. Healthcare. 12(21). 2196–2196. 1 indexed citations
3.
Ramis, Damià, et al.. (2024). Haematological alterations in the context of olanzapine treatment. European Psychiatry. 67(S1). S691–S692.
4.
Catalán, Rosa, et al.. (2024). NRN1 genetic variability and methylation changes as biomarkers for cognitive remediation therapy response in schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 136. 111175–111175.
5.
Andersen, Stig Ejdrup, María J. Arranz, Rosa Catalán, et al.. (2022). CYP2D6 Genetic Variation and Antipsychotic-Induced Weight Gain: A Systematic Review and Meta-Analysis. Frontiers in Psychology. 12. 768748–768748. 10 indexed citations
6.
Mitjans, Marina, Rosa Catalán, Alexandre González-Rodríguez, et al.. (2015). Hypothalamic–pituitary–adrenal system, neurotrophic factors and clozapine response. Pharmacogenetics and Genomics. 25(5). 274–277. 20 indexed citations
7.
Arias, Bárbara, Chiara Fabbri, Alessandro Serretti, et al.. (2014). DISC1-TSNAX and DAOA genes in major depression and citalopram efficacy. Journal of Affective Disorders. 168. 91–97. 12 indexed citations
8.
González-Rodríguez, Alexandre, et al.. (2013). Effectiveness of long-acting injectable antipsychotics in delusional disorders with nonprominent hallucinations and without hallucinations. International Clinical Psychopharmacology. 29(3). 177–180. 16 indexed citations
9.
Mitjans, Marina, Alessandro Serretti, Chiara Fabbri, et al.. (2013). Screening genetic variability at the CNR1 gene in both major depression etiology and clinical response to citalopram treatment. Psychopharmacology. 227(3). 509–519. 46 indexed citations
10.
Arias, Bárbara, Chiara Fabbri, Florence Gressier, et al.. (2012). TPH1, MAOA, Serotonin Receptor 2A and 2C Genes in Citalopram Response: Possible Effect in Melancholic and Psychotic Depression. Neuropsychobiology. 67(1). 41–47. 27 indexed citations
11.
Mitjans, Marina, Cristòbal Gastó, Rosa Catalán, Lourdes Fañanás, & Bárbara Arias. (2012). Genetic variability in the endocannabinoid system and 12-week clinical response to citalopram treatment: the role of the CNR1, CNR2 and FAAH genes. Journal of Psychopharmacology. 26(10). 1391–1398. 24 indexed citations
12.
Arias, Bárbara, Alessandro Serretti, Laura Mandelli, et al.. (2009). Dysbindin gene (DTNBP1) in major depression: association with clinical response to selective serotonin reuptake inhibitors. Pharmacogenetics and Genomics. 19(2). 121–128. 24 indexed citations
13.
Lafuente, Amàlia, Miquel Bernardo, Sergi Mas, et al.. (2008). -141C Ins/Del polymorphism of the dopamine D2 receptor gene is associated with schizophrenia in a Spanish population. Psychiatric Genetics. 18(3). 122–127. 25 indexed citations
14.
15.
Gutiérrez, Blanca, Araceli Rosa, Sergi Papiol, et al.. (2007). Identification of two risk haplotypes for schizophrenia and bipolar disorder in the synaptic vesicle monoamine transporter gene (SVMT). American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 144B(4). 502–507. 16 indexed citations
16.
Arias, Bárbara, Alessandro Serretti, Cristina Lorenzi, et al.. (2005). Analysis of COMT gene (Val 158 Met polymorphism) in the clinical response to SSRIs in depressive patients of European origin. Journal of Affective Disorders. 90(2-3). 251–256. 86 indexed citations
17.
Papiol, Sergi, Bárbara Arias, Neus Barrantes‐Vidal, et al.. (2004). Analysis of polymorphisms at the tumor suppressor gene p53 (TP53) in contributing to the risk for schizophrenia and its associated neurocognitive deficits. Neuroscience Letters. 363(1). 78–80. 18 indexed citations
18.
Arias, Bárbara, Rosa Catalán, Cristòbal Gastó, Blanca Gutiérrez, & Lourdes Fañanás. (2003). 5-HTTLPR Polymorphism of the Serotonin Transporter Gene Predicts Non-Remission in Major Depression Patients Treated With Citalopram in a 12-Weeks Follow Up Study. Journal of Clinical Psychopharmacology. 23(6). 563–567. 146 indexed citations
19.
Arias, Bárbara, Cristòbal Gastó, Rosa Catalán, et al.. (2001). The 5‐HT2A receptor gene 102T/C polymorphism is associated with suicidal behavior in depressed patients. American Journal of Medical Genetics. 105(8). 801–804. 65 indexed citations
20.
Moreno, Pau, et al.. (1999). Total rupture of the gastro-oesophageal junction after blunt trauma. The European Journal of Surgery. 165(1). 73–74. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Silvia Paddock Breakdown of academic impact, for papers by Alexa J.M. Sorant Breakdown of academic impact, for papers by Jeffrey Kraft Breakdown of academic impact, for papers by Johannes M. Hennings Breakdown of academic impact, for papers by Christo Minov Breakdown of academic impact, for papers by Rhee-Hun Kang Breakdown of academic impact, for papers by Yoshiteru Takekita Breakdown of academic impact, for papers by Bianca Wollenhaupt de Aguiar Breakdown of academic impact, for papers by Hitoshi Maeshima Breakdown of academic impact, for papers by Myoung-Jin Choi
Rankless by CCL
2026